Market cap
₹83 Cr
Revenue (TTM)
₹160 Cr
P/E Ratio
9.7
P/B Ratio
0.7
Div. Yield
4 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -18.45 | 39.33 | -6.51 | -26.19 | -23.32 |
| EBIT | -277.56 | 43.66 | 27.42 | 23.19 | 12.75 |
| Net Profit | -72.58 | 132.09 | 189.05 | 30.71 | 18.03 |
| EPS | -72.64 | 132.02 | 189.08 | -50.39 | 18.03 |
| Book Value | -- | -- | 12.22 | 8.95 | 44.15 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Mar-26 | Mar-25 |
| EBIT-Margin
| -105.96 | -4.84 | -3.16 | -5.23 | -1.82 |
| Net Margin
| 35.27 | 3.41 | 4.89 | 4.05 | 2.63 |
| Return on equity
| 23.93 | 58.49 | 7.41 | 6.02 | 4.71 |
| Return on Capital
| 26.81 | 17.32 | -- | 7.92 | 6.62 |
| Return on Assets
| 19.46 | 6.06 | 6.00 | 4.74 | 3.64 |
| Debt to Equity (x)
| -- | -- | 0.00 | 0.00 | 0.00 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Cravatex
|
--
|
7.92
|
6.62
|
6.87
|
68.80
|
|
Peer Median
|
--
|
17.84
|
13.65
|
20.51
|
--
|
ROE
7.41
Lower than Peers by 4.18
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Cravatex
|
7.41
|
6.02
|
4.71
|
5.05
|
276.70
|
|
Peer Median
|
11.59
|
14.23
|
11.89
|
15.90
|
--
|
ROA
6.00
Lower than Peers by 0.25
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Cravatex
|
6.00
|
4.74
|
3.64
|
3.70
|
23.51
|
|
Peer Median
|
6.25
|
6.13
|
5.53
|
7.64
|
--
|
EBIT Margin
-3.16
Lower than Peers by 10.65
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Cravatex
|
-3.16
|
-5.23
|
-1.82
|
-4.70
|
-9.14
|
|
Peer Median
|
7.49
|
8.80
|
8.19
|
8.54
|
--
|
Net Margin
4.89
Lower than Peers by 2.02
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Cravatex
|
4.89
|
4.05
|
2.63
|
2.21
|
11.42
|
|
Peer Median
|
6.91
|
6.95
|
5.47
|
6.56
|
--
|
Cash Profit Margin
--
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Cravatex
|
--
|
5.50
|
3.63
|
3.31
|
14.91
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
-6.51
Lower than Peers by 15.64
Year on year growth in net sales
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Cravatex
|
-6.51
|
-13.17
|
-14.25
|
-59.77
|
-15.26
|
|
Peer Median
|
9.13
|
15.07
|
29.72
|
7.05
|
--
|
EBIT Growth
27.42
Higher than Peers by 16.71
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Cravatex
|
27.42
|
-149.88
|
66.84
|
79.29
|
-134.21
|
|
Peer Median
|
10.71
|
22.74
|
23.89
|
18.97
|
--
|
Net Profit Growth
189.05
Higher than Peers by 174.30
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Cravatex
|
189.05
|
40.77
|
0.02
|
-91.81
|
396.33
|
|
Peer Median
|
14.75
|
19.71
|
23.03
|
10.54
|
--
|
EPS Growth
189.08
Higher than Peers by 185.05
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Cravatex
|
189.08
|
40.77
|
0.02
|
-91.81
|
396.34
|
|
Peer Median
|
4.03
|
9.13
|
4.03
|
9.38
|
--
|
Book Value Growth
--
--
Year on year growth in book value per share
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Cravatex
|
--
|
12.22
|
7.80
|
6.89
|
285.59
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Cravatex
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.01
|
0.35
|
0.49
|
0.32
|
--
|
Short term debt to equity ratio
--
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Cravatex
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
5.62
Higher than Peers by 3.86
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Cravatex
|
5.62
|
5.62
|
4.22
|
5.11
|
2.95
|
|
Peer Median
|
1.76
|
2.02
|
1.76
|
1.79
|
--
|
Quick Ratio
4.68
Higher than Peers by 3.64
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Cravatex
|
4.68
|
4.68
|
3.86
|
4.64
|
2.27
|
|
Peer Median
|
1.05
|
1.29
|
0.99
|
1.05
|
--
|
Interest Coverage
31.83
Higher than Peers by 27.98
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Cravatex
|
31.83
|
24.60
|
16.41
|
16.10
|
5.22
|
|
Peer Median
|
3.85
|
4.18
|
3.00
|
4.17
|
--
|
Operating Efficiency
Debtors to sales
10.21
Lower than Peers by 17.32
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Cravatex
|
10.21
|
10.82
|
13.79
|
6.83
|
5.20
|
|
Peer Median
|
27.53
|
27.39
|
32.90
|
23.57
|
--
|
Asset Turnover
1.12
Higher than Peers by 0.21
Sales / Average Total Assets
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Cravatex
|
1.12
|
1.05
|
1.31
|
1.55
|
2.01
|
|
Peer Median
|
0.91
|
1.05
|
1.13
|
1.06
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Cravatex
|
--
|
48.74
|
39.71
|
36.08
|
57.77
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Cravatex
|
--
|
41.71
|
23.26
|
35.77
|
44.71
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Cravatex
|
--
|
49.54
|
38.15
|
40.41
|
30.99
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Cravatex
|
--
|
40.91
|
24.82
|
31.43
|
71.48
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
9.70
Lower than Peers by 30.65
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Cravatex
|
9.70
|
11.60
|
18.34
|
23.40
|
1.40
|
|
Peer Median
|
40.36
|
27.39
|
36.20
|
31.36
|
--
|
Price / Book Value
0.70
Lower than Peers by 1.86
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Cravatex
|
0.70
|
0.66
|
0.83
|
1.14
|
0.90
|
|
Peer Median
|
2.56
|
2.71
|
4.03
|
3.69
|
--
|
Dividend Yield
4.02
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Cravatex
|
4.02
|
4.26
|
3.65
|
0.69
|
0.47
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
0.55
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Cravatex
|
0.55
|
0.22
|
1.58
|
4.37
|
-1.51
|
|
Peer Median
|
--
|
18.75
|
22.54
|
19.25
|
--
|
Market Cap
83
Lower than Peers by 1,014
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Cravatex
|
83
|
79
|
89
|
113
|
83
|
|
Peer Median
|
1,097
|
489
|
714
|
610
|
--
|